The Master of Science in Applied Biomedicine (MSc ABM) at the NUS Yong Loo Lin School of Medicine is a postgraduate program designed to advance expertise in key areas of biomedicine. With options for both full-time (1 year) and part-time (2 years) study, this coursework-based program offers specializations in Vaccinology and Immunotherapy, Infectious Disease Management, and Drug Discovery and Development. The MSc ABM aims to cultivate critical thinking and analytical skills, preparing graduates to be adaptable leaders within the healthcare and biopharmaceutical industries. The program is structured to equip students with up-to-date knowledge and practical skills, ensuring they can meet the demands of research institutes, government ministries, and hospitals, particularly in fields such as infectious diseases, vaccine development, and drug discovery.
The MSc ABM program requires a total of 40 units for graduation. Students can choose to focus on a specific specialization or pursue a non-specialisation track. The program structure includes core courses, compulsory courses within a chosen specialization, and either a capstone project or elective courses.
Graduates of the MSc ABM program are prepared for diverse roles within the healthcare and biopharmaceutical sectors. The skills acquired enable them to contribute to research, development, and management in various biomedical fields.
Selection of candidates is competitive, and meeting minimum requirements does not guarantee admission. The university does not engage external recruitment agents.
Tuition fee details are not provided in the source documents.
Applicants should hold a Bachelor's degree in Life Sciences, Bioengineering, Medicine, or a related field. Admission is competitive, and meeting the minimum requirements does not guarantee acceptance.
The program can be completed in 1 year of full-time study or 2 years of part-time study.
Students can specialize in Vaccinology and Immunotherapy, Infectious Disease Management, or Drug Discovery and Development. A non-specialisation track is also available.
A total of 40 units are required for graduation. This includes core courses, specialization courses, and either a capstone project or elective courses.
Applications for the August intake open on 1 September 2025 and close on 30 April 2026.
Graduates are prepared for roles such as Medical Technologists, Biochemists, Research Scientists, Toxicologists, Microbiologists, and Regulatory Specialists in the healthcare and biopharmaceutical sectors.